Vandana Singh
·
April 29, 2025
Benzinga
FDA approves Zevaskyn as the first cell-based gene therapy for RDEB wounds after strong results in pivotal and long-term studies.
read more
May 9, 2025
February 28, 2025
March 5, 2025
Barchart